Supplementary Table 1. Percent Change in TG (Analysis of Dose-Response Relationship).
Least squares | 95%CI | P value | |
---|---|---|---|
Placebo | −2.8 ± 4.5 | −11.8, 6.2 | 0.538 |
Pemafibrate 0.1 mg/day | −46.3 ± 2.8 | −51.8, −40.9 | < 0.001 |
Pemafibrate 0.2 mg/day | −46.8 ± 1.6 | −50.0, −43.5 | < 0.001 |
Pemafibrate 0.4 mg/day | −51.9 ± 2.0 | −55.8, −48.0 | < 0.001 |
Contrast | F value | P value | Adjusted P value* |
---|---|---|---|
(−3 −1 1 3) | 96.7 | < 0.001 | |
(−5 −1 3 3) | 98.2 | < 0.001 | < 0.001 |
(−3 1 1 1) | 96.6 | < 0.001 |
Data are presented as least squares mean ± SE.
Multiplicity adjusted (contrast: maximum contrast method)
TG, triglyceride; CI, confidence interval; SE, standard error